Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|May 22, 2010
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)Eric H Kraut, Christopher Rhoades, Yilong Zhang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 22, 2021
Evaluation of MTBH, a novel hesperetin derivative, on the activity of hepatic cytochrome P450 isoform <i>in vitro</i> and <i>in vivo</i> using a cocktail method by HPLC-MS/MSYan Qin, Haijun Dong, Jiayin Sun, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 20, 2014
FLT3 and CDK4/6 inhibitors: signaling mechanisms and tumor burden in subcutaneous and orthotopic mouse models of acute myeloid leukemiaYaping Zhang, Cheng-Pang Hsu, Jian-Feng Lu, et al.
The Journal of Investigative Dermatology|April 26, 2022
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient CohortGregory A Chang, Eric Robinson, Jennifer M Wiggins, et al.
International Journal of Epidemiology|July 11, 2019
PM2.5 air pollution and cause-specific cardiovascular disease mortalityRichard B Hayes, Chris Lim, Yilong Zhang, et al.
Molecular Oncology|October 7, 2015
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progressionGregory A Chang, Jyothirmayee S Tadepalli, Yongzhao Shao, et al.
The Science of the Total Environment|October 17, 2015
Contrasting distributions of groundwater arsenic and uranium in the western Hetao basin, Inner Mongolia: Implication for origins and fate controlsHuaming Guo, Yongfeng Jia, Richard B Wanty, et al.
Clinical Lung Cancer|June 12, 2017
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung CancerBonnie Glisson, Benjamin Besse, Manuel Cobo Dols, et al.
Diabetes, Obesity & Metabolism|November 6, 2018
Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I StudyRonan Roussel, Santiago Duran-García, Yilong Zhang, et al.
The Journal of Bone and Joint Surgery. American Volume|December 17, 2025
Bezeotermin Alfa (rhBMP-6) Administration in Lumbar Interbody Fusion Surgery Using a Posterior Approach: A Randomized, Double-Blinded, Placebo-Controlled Phase-2 StudyWeishi Li, Xiaoji Luo, Xiaozhong Zhou, et al.
Pageof 17